FDANonrulemakingFDA-2011-D-0597

Who commented on this docket

Industry on Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring

1 organizations filed 1 public comment on Industry on Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring, at the Food and Drug Administration. The comment window closed 2630d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2630d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.